JENELLE ROBINSON: Open Payments
NPI 1689986168 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 115 payments from 26 companies in 2025. Trend: 2023 $807 · 2024 $2,003 · 2025 $2,310
Food & beverage: $2,268Education: $43
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 20 | $355 |
| Abbott Laboratories | 4 | $211 |
| Insulet Corporation | 22 | $189 |
| Corcept Therapeutics | 11 | $189 |
| CeQur Corporation | 1 | $161 |
| Amgen Inc. | 8 | $146 |
| Xeris Pharmaceuticals, Inc. | 9 | $137 |
| Ascendis Pharma Endocrinology Inc | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 5 | $104 |
| Tandem Diabetes Care, Inc. | 4 | $87 |
Products named: MOUNJARO, FREESTYLE LIBRE 3, Omnipod, Korlym, JARDIANCE, CeQur Simplicity, TEPEZZA, Yorvipath.
Industry payments across CA — which companies pay providers there.
